Orthopaedic surgeons and thromboprophylaxis.
出版信息
BMJ. 1991 Nov 9;303(6811):1202-3. doi: 10.1136/bmj.303.6811.1202-c.
Abstract
摘要
相似文献
1
Orthopaedic surgeons and thromboprophylaxis.骨科外科医生与血栓预防
BMJ. 1991 Nov 9;303(6811):1202-3. doi: 10.1136/bmj.303.6811.1202-c.
2
Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.择期髋关节手术中使用肝素和低分子肝素进行血栓预防：现状与展望。
Semin Thromb Hemost. 1991 Oct;17(4):336-42. doi: 10.1055/s-2007-1002631.
3
Orthopaedic surgeons and thromboprophylaxis.骨科医生与血栓预防
BMJ. 1991 Oct 12;303(6807):923. doi: 10.1136/bmj.303.6807.923.
4
Hirudin CGP 39393 as thromboprophylaxis.水蛭素CGP 39393用于血栓预防。
Lancet. 1996 Jun 1;347(9014):1561-2. doi: 10.1016/s0140-6736(96)90718-7.
5
Cost/benefit aspects on thromboprophylaxis.
Haemostasis. 1993 Mar;23 Suppl 1:15-9. doi: 10.1159/000216904.
6
Current UK opinion on thromboprophylaxis in orthopaedic surgery: its use in routine total hip and knee arthroplasty.英国目前关于骨科手术中血栓预防的观点：其在常规全髋关节和膝关节置换术中的应用。
Ann R Coll Surg Engl. 1995 Sep;77(5):351-4.
7
[Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement].髋关节置换术后应用肝素和双氢麦角胺预防术后静脉血栓栓塞
MMW Munch Med Wochenschr. 1979 Sep 7;121(36):1152-4.
8
Major orthopaedic surgery on the leg and thromboembolism.腿部大骨科手术与血栓栓塞
BMJ. 1991 Sep 7;303(6802):531-2. doi: 10.1136/bmj.303.6802.531.
9
10
[Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution].
Minerva Anestesiol. 1990 Oct;56(10):1117-20.
本文引用的文献
1
Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.全髋关节置换术后预防深静脉血栓形成中，调整剂量皮下注射肝素与固定剂量皮下注射肝素的比较
N Engl J Med. 1983 Oct 20;309(16):954-8. doi: 10.1056/NEJM198310203091605.
2
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.一项关于低分子量肝素（依诺肝素）预防择期髋关节手术患者深静脉血栓形成的随机对照试验。
N Engl J Med. 1986 Oct 9;315(15):925-9. doi: 10.1056/NEJM198610093151503.
3
The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg.低分子量肝素依诺肝素在单次皮下注射20至80毫克剂量的人体中的抗血栓活性和药代动力学。
J Clin Pharmacol. 1988 Jul;28(7):609-18. doi: 10.1002/j.1552-4604.1988.tb03184.x.
4
Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.重大骨科手术患者静脉血栓形成的预防
Br J Clin Pract Suppl. 1989 Jan;65:2-8.
5
Total hip replacement and deep vein thrombosis. A venographic and necropsy study.全髋关节置换与深静脉血栓形成。一项静脉造影和尸检研究。
J Bone Joint Surg Br. 1990 Jan;72(1):9-13. doi: 10.1302/0301-620X.72B1.2298803.
6
Orthopaedic surgeons and thromboprophylaxis.骨科外科医生与血栓预防
BMJ. 1991 Sep 7;303(6802):549-50. doi: 10.1136/bmj.303.6802.549.
7
Efficacy of fixed minidose warfarin prophylaxis in total hip replacement.固定小剂量华法林预防全髋关节置换术的疗效
BMJ. 1991 Jul 27;303(6796):219-20. doi: 10.1136/bmj.303.6796.219.
8
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.髋关节置换术后深静脉血栓形成的预防：普通肝素与低分子量肝素的随机对照比较。
BMJ. 1991 Sep 7;303(6802):543-8. doi: 10.1136/bmj.303.6802.543.
Zotero 插件